ASRM

Generate Life Sciences Details Data Presented at the 2021 Annual ASRM and AABB Meetings

Thursday, October 21, 2021 - 1:00pm

LOS ANGELES, Oct. 21, 2021 /PRNewswire/ -- Generate Life Sciences recently presented data from its research programs during this year's American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo and the AABB (formerly known as the American Association of Blood Banks) Annual Meeting.

Key Points: 
  • LOS ANGELES, Oct. 21, 2021 /PRNewswire/ -- Generate Life Sciences recently presented data from its research programs during this year's American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo and the AABB (formerly known as the American Association of Blood Banks) Annual Meeting.
  • "Constantly moving the research field forward is imperative for improving reproductive health services," said Kate Brown, Ph.D., Senior Director of Science at Generate.
  • All of our presented studies addressed fundamental questions that are vital for setting up future research."
  • Generate Life Sciences is a global life sciences company helping families setting out to grow and protect their future, through guidance anchored in scientific advancements and services ranging from preconception into adulthood.

Thirteen Ovation Research Abstracts Accepted for Presentation at ASRM 2021

Thursday, October 21, 2021 - 8:00am

Nashville, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Ovation Fertility teams are presenting three oral presentations and 10 poster presentations at the 2021 ASRM Scientific Congress & Expo, which takes place both virtually and in-personin Baltimore October 17-20, 2021.

Key Points: 
  • Nashville, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Ovation Fertility teams are presenting three oral presentations and 10 poster presentations at the 2021 ASRM Scientific Congress & Expo, which takes place both virtually and in-personin Baltimore October 17-20, 2021.
  • Additionally, Ovation scientists are leading interactive sessions and roundtable discussions at the annual event, where top experts in reproductive medicine discuss the latest in reproductive care.
  • The list of Ovation abstracts and presentations accepted for ASRM 2021 covers a wide range of groundbreaking findings in the fields of IVF, genetic testing, and the use of artificial intelligence in embryo selection.
  • Ovation also helps IVF labs across America improve their quality and performance with expert off-site lab direction and consultation.

INVO Bioscience Announces Four Individual Poster Abstracts Discussing the Benefits of INVOcell Presented at the 2021 American Society for Reproductive Medicine (ASRM) Congress & Expo

Wednesday, October 20, 2021 - 2:00pm

Steve Shum, CEO of INVO Bioscience, commented, "It's extremely rewarding to see our technology highlighted at this year's ASRM.

Key Points: 
  • Steve Shum, CEO of INVO Bioscience, commented, "It's extremely rewarding to see our technology highlighted at this year's ASRM.
  • A COMPARISON OF SIBLING EMBRYO DEVELOPMENT AND PREGNANCY RATES THROUGH INVOCELL AND CONVENTIONAL IVF.
  • USE OF INVOCELL INTRAVAGINAL EMBRYO CULTURE SYSTEM FOR FIVE DAYS OF INCUBATION: A PROSPECTIVE STUDY OF SAFETY AND TOLERABILITY.
  • Our lead product, the INVOcell, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART).

ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix for the Treatment of Uterine Fibroids at ASRM 2021 Scientific Congress & Expo

Wednesday, October 20, 2021 - 6:00am

Key takeaway: Once daily treatment of 200 mg linzagolix without ABT reduced uterine volume by 39% after 24 weeks.

Key Points: 
  • Key takeaway: Once daily treatment of 200 mg linzagolix without ABT reduced uterine volume by 39% after 24 weeks.
  • This single-center, open-label, exploratory study was designed to assess the efficacy and safety of linzagolix in the treatment of symptomatic adenomyosis.
  • Linzagolix is a novel, once daily, oral GnRH receptor antagonist with a potentially best-in-class profile1,2,3.
  • Linzagolix has completed clinical trial development for the treatment of heavy menstrual bleeding associated with uterine fibroids and is currently in late-stage clinical development for the treatment of pain associated with endometriosis.

Reproductive Medicine Associates of New York Presents Innovative Research at ASRM's 77th Annual Meeting

Tuesday, October 19, 2021 - 4:00pm

BALTIMORE, Md., Oct. 19, 2021 /PRNewswire/ --Physicians and scientists at Reproductive Medicine Associates of New York (RMA of New York) and the Icahn School of Medicine at Mount Sinai Hospital in New York presented a record 35 original scientific abstracts at the 77th annual meeting of the American Society for Reproductive Medicine (ASRM) in Baltimore, Maryland.

Key Points: 
  • BALTIMORE, Md., Oct. 19, 2021 /PRNewswire/ --Physicians and scientists at Reproductive Medicine Associates of New York (RMA of New York) and the Icahn School of Medicine at Mount Sinai Hospital in New York presented a record 35 original scientific abstracts at the 77th annual meeting of the American Society for Reproductive Medicine (ASRM) in Baltimore, Maryland.
  • Research topics included single cell DNA sequencing, disparities in health care outcomes, and the impact of the COVID-19 pandemic on the patient journey.
  • Her research on single cell sequencing of whole human blastocystsexpands our current understanding of the genetic composition of human embryos.
  • About Reproductive Medicine Associates of New York, LLP
    Reproductive Medicine Associates of New York (RMA of New York) is widely recognized as a global leader in state-of-the-art reproductive medicine.

ObsEva Announces Presentation of Clinical Data on Oral GnRH Antagonist Linzagolix at ASRM 2021 Scientific Congress & Expo

Tuesday, October 19, 2021 - 6:00am

GENEVA, Switzerland October 19, 2021 ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health, today announced two upcoming poster presentations on linzagolix, an oral GnRH antagonist, at the American Society for Reproductive Medicine (ASRM) 2021 Scientific Congress & Expo, being held October 17-20, 2021.

Key Points: 
  • GENEVA, Switzerland October 19, 2021 ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health, today announced two upcoming poster presentations on linzagolix, an oral GnRH antagonist, at the American Society for Reproductive Medicine (ASRM) 2021 Scientific Congress & Expo, being held October 17-20, 2021.
  • ET
    Session Date & Time: Poster presentation will be available through theASRM conference portal, on Wednesday, October 20, 2021, from 6:30-7:45 a.m.
  • ET
    ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health and pregnancy.
  • These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements.

Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women

Friday, October 15, 2021 - 11:50am

The website aims to meet people wherever they are on their fertility journey and equip them with knowledge and questions for consideration to feel prepared and empowered throughout their journey.

Key Points: 
  • The website aims to meet people wherever they are on their fertility journey and equip them with knowledge and questions for consideration to feel prepared and empowered throughout their journey.
  • We want to provide support to anyone looking to start a family and for those accompanying them.
  • I am proud to work at Organon where we are truly devoted to understanding the journey.
  • Every fertility journey is a personal one, but many on this road have similar questions.

Advancements in reproductive medicine available at Shady Grove Fertility (SGF) can reduce the inheritance of genetic diseases like breast cancer

Thursday, October 14, 2021 - 1:45pm

Individuals and couples with known genetic diseases can turn to Shady Grove Fertility (SGF) to undergo in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects(PGT-M) to reduce the risk of passing genetic mutations to future offspring.

Key Points: 
  • Individuals and couples with known genetic diseases can turn to Shady Grove Fertility (SGF) to undergo in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects(PGT-M) to reduce the risk of passing genetic mutations to future offspring.
  • Additionally, patients at risk for dominant gene mutations, such as breast cancer or inherited forms of colon cancer, can have individualized testing for these diseases.
  • While Rose is not a carrier for the breast cancer gene, she is a carrier of a rare X-linked genetic mutation called Wiskott-Aldrich syndrome.
  • We are so fortunate to live in a world where we can now reduce the inheritance of deadly genetic diseases via IVF.

Reproductive Biology Associates Welcomes Erin Lewis, MD to its Renowned Team of Reproductive Endocrinologists

Thursday, October 7, 2021 - 11:16pm

"We look forward to the contributions Dr. Lewis will make to our practice and the impact she will have on our patients."

Key Points: 
  • "We look forward to the contributions Dr. Lewis will make to our practice and the impact she will have on our patients."
  • A member of the American Society of Reproductive Medicine (ASRM), Dr. Lewis is board-certified in Obstetrics and Gynecology (OB/GYN) and Reproductive Endocrinology and Infertility (REI).
  • She completed her REI fellowship at Brigham and Women's Hospital and her OB/GYN residency at UCLA Medical Center.
  • With more than 70 internationally recognized reproductive endocrinologists, Prelude places emphasis on the best clinical protocols and scientific advancements and sharing these best practices across its network.

Shady Grove Fertility's (SGF) Colorado Springs Physician, Shona Murray, M.D., Named to Colo|Spgs Magazine's 2021 Top Doctors List

Thursday, September 30, 2021 - 10:05pm

COLORADO SPRINGS, Colo., Sept. 30, 2021 /PRNewswire-PRWeb/ --Shady Grove Fertility (SGF) is proud to announce that Shona Murray, M.D.

Key Points: 
  • COLORADO SPRINGS, Colo., Sept. 30, 2021 /PRNewswire-PRWeb/ --Shady Grove Fertility (SGF) is proud to announce that Shona Murray, M.D.
  • , who sees patients at SGF's Colorado Springs office , has again been named to Colo|Spgs Magazine's 2021 Top Doctors list following multiple distinctions since her first recognition in 2011.
  • Colo|Spgs Magazine, previously known as Colorado Springs Style, conducts an annual peer-to-peer survey by Perini & Associates, an independent firm with no ties to the magazine or the medical community.
  • The Colorado Springs location offers comprehensive fertility services, including:
    fertility and ovarian reserve testing and diagnosis,